SOOFT ITALIA S P A has a total of 20 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), Italy and Serbia. Its main competitors in its focus markets pharmaceuticals and medical technology are FERX INC, ADVANCED NEUROREGENERATIVE THERAPIES LLC and NANOBIOTIX.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 12 | |
#2 | Italy | 3 | |
#3 | Serbia | 2 | |
#4 | Argentina | 1 | |
#5 | Hungary | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Electrotherapy | |
#4 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Stagni Edoardo | 14 |
#2 | Biondi Piero | 12 |
#3 | Cavallo Giovanni | 7 |
#4 | Stagni Marcello | 7 |
#5 | Luciani Giulio | 5 |
#6 | Roy Pierre | 5 |
#7 | Biondi Marco | 5 |
#8 | Foschini Fulvio | 5 |
#9 | Biondi Chiara | 2 |
#10 | Sodo Eugenio | 2 |
Publication | Filing date | Title |
---|---|---|
EP3130335A1 | Ophthalmic composition comprising inositol for improving visual accomodation | |
ITUB20160121A1 | GABAPENTIN OFTALMIC FOR THE TREATMENT OF CORNEAL ULCERS | |
EP2494954A2 | Ophthalmic composition based on lactobionic acid useful for reducing corneal edema and inflammation | |
EP2663281A1 | Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions | |
EP2323642A1 | Use of EDTA+tromethamine or of photoenhancers, associated to riboflavin for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders |